Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Rein Therapeutics Inc. RNTX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
41/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+237.1%

Rein Therapeutics Inc. (RNTX) has 10 identified peers for comparison in the Healthcare sector. Peers include ATNM, BCAB, BEAT, CELU, KZR, MRSN and others.

RNTX has a market capitalization of $49.91M, compared to an average peer market cap of $39.95M.

People Also View

MRSN
MRSN
Mersana Therapeutics, Inc.
$29.08
+0.00%
 YI
YI
111, Inc.
$6.86
+0.73%
 KZR
KZR
Kezar Life Sciences, Inc.
$7.38
+0.27%
 ATNM
ATNM
Actinium Pharmaceuticals, Inc.
$1.26
+14.55%
 CELU
CELU
Celularity Inc.
$1.25
-3.85%
 BEAT
BEAT
HeartBeam, Inc.
$0.87
-27.52%
 NOTV
NOTV
Inotiv, Inc.
$0.39
+59.02%
 QNTM
QNTM
Quantum BioPharma Ltd.
$3.07
+1.66%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message